Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.
2013 Officers - all terms run from July 1, 2012 to June 30, 2013
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Linda A. Miller
Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms
Divisional Group Representative
University of Michigan
Ann Arbor, MI